DCF — LAREDO MEDICAL CENTER
Enterprise Value: $195.2M
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
$195.2M
Enterprise Value
$49.7M
PV of Cash Flows
$145.5M
PV of Terminal Value
$234.3M
Terminal Value
10.0%
WACC
2.5%
Terminal Growth
Cash Flow Projections
PROJ| Year | Revenue | EBITDA | Margin | FCF | PV(FCF) |
|---|---|---|---|---|---|
| Year 1 | $315.4M | $26.8M | 8.0% | $8.7M | $7.9M |
| Year 2 | $324.9M | $30.9M | 9.0% | $11.4M | $9.4M |
| Year 3 | $334.6M | $35.1M | 10.0% | $14.3M | $10.7M |
| Year 4 | $344.7M | $37.9M | 11.0% | $16.0M | $10.9M |
| Year 5 | $355.0M | $39.9M | 11.0% | $17.1M | $10.6M |
Interpretation
INTAt a WACC of 10.0% and terminal growth of 2.5%, enterprise value is $195.2M. Terminal value accounts for 75% of total EV — typical range (60-80%).
Next steps: Check the LBO model to see equity returns at this entry price, or the EBITDA bridge to model value creation levers.
Assumptions
ASSMrevenue base$306.2M
revenue growth rates[0.03, 0.03, 0.03, 0.03, 0.03]
ebitda margin base0.07999999960815432
ebitda margin improvement bps[50, 100, 100, 50, 25]
capex pct revenue0.04
nwc pct revenue0.08
tax rate0.25
projection years5